Table 2.2.
Evidence syntheses published by Cochrane and JBI
| Cochrane Database of Systematic Reviews a | JBI Evidence Synthesis b | ||||
|---|---|---|---|---|---|
| Category | N | % | Category | N | % |
| Intervention | 8,572 | 96.3 | Effectiveness | 435 | 61.5 |
| Diagnostic | 176 | 1.9 | Diagnostic Test Accuracy | 9 | 1.3 |
| Overview | 64 | 0.7 | Umbrella | 4 | 0.6 |
| Methodology | 41 | 0.45 | Mixed Methods | 2 | 0.3 |
| Qualitative | 17 | 0.19 | Qualitative | 159 | 22.5 |
| Prognostic | 11 | 0.12 | Prevalence and Incidence | 6 | 0.8 |
| Rapid | 11 | 0.12 | Etiology and Risk | 7 | 1.0 |
| Prototypec | 8 | 0.08 | Measurement Properties | 3 | 0.4 |
| Economic | 6 | 0.6 | |||
| Text and Opinion | 1 | 0.14 | |||
| Scoping | 43 | 6.0 | |||
| Comprehensived | 32 | 4.5 | |||
| Total=8900 | Total=707 | ||||
Data from https://www.cochranelibrary.com/cdsr/reviews. Accessed 17 Sep 2022.
Data obtained via personal email communication on 18 Sep 2022 with Emilie Francis, editorial assistant, JBI Evidence Synthesis.
Includes the following categories: prevalence, scoping, mixed methods, and realist reviews.
This methodology is not supported in the current version of the JBI Manual for Evidence Synthesis.